ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $14,000 | -50.0% | 22,097 | +144.3% | 0.00% | -50.0% |
Q3 2016 | $28,000 | +133.3% | 9,045 | +115.1% | 0.00% | +100.0% |
Q2 2016 | $12,000 | -40.0% | 4,205 | -23.9% | 0.00% | -50.0% |
Q1 2016 | $20,000 | +1900.0% | 5,525 | +1741.7% | 0.00% | – |
Q1 2015 | $1,000 | -87.5% | 300 | -94.3% | 0.00% | -100.0% |
Q4 2014 | $8,000 | – | 5,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
Abingworth LLP | 437,994 | $679,000 | 0.19% |
GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
BVF INC/IL | 559,624 | $884,000 | 0.17% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
Perceptive Advisors | 503,156 | $795,000 | 0.07% |
Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |